139 related articles for article (PubMed ID: 7720663)
1. Interleukin-6 stimulates hepatic triglyceride secretion in rats.
Nonogaki K; Fuller GM; Fuentes NL; Moser AH; Staprans I; Grunfeld C; Feingold KR
Endocrinology; 1995 May; 136(5):2143-9. PubMed ID: 7720663
[TBL] [Abstract][Full Text] [Related]
2. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo.
Nonogaki K; Moser AH; Pan XM; Staprans I; Grunfeld C; Feingold KR
J Lipid Res; 1995 Sep; 36(9):1987-95. PubMed ID: 8558086
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte growth factor increases fatty acid mobilization and hepatic triglyceride secretion in rats.
Nonogaki K; Pan XM; Moser AH; Staprans I; Feingold KR; Grunfeld C
Endocrinology; 1995 Oct; 136(10):4278-84. PubMed ID: 7664645
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
Feingold KR; Staprans I; Memon RA; Moser AH; Shigenaga JK; Doerrler W; Dinarello CA; Grunfeld C
J Lipid Res; 1992 Dec; 33(12):1765-76. PubMed ID: 1479286
[TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor.
Feingold KR; Soued M; Adi S; Staprans I; Neese R; Shigenaga J; Doerrler W; Moser A; Dinarello CA; Grunfeld C
Arterioscler Thromb; 1991; 11(3):495-500. PubMed ID: 2029492
[TBL] [Abstract][Full Text] [Related]
6. Alpha-adrenergic receptors mediate the hypertriglyceridemia induced by endotoxin, but not tumor necrosis factor, in rats.
Nonogaki K; Moser AH; Feingold KR; Grunfeld C
Endocrinology; 1994 Dec; 135(6):2644-50. PubMed ID: 7988454
[TBL] [Abstract][Full Text] [Related]
7. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production.
Feingold KR; Adi S; Staprans I; Moser AH; Neese R; Verdier JA; Doerrler W; Grunfeld C
Am J Physiol; 1990 Aug; 259(2 Pt 1):E177-84. PubMed ID: 2382712
[TBL] [Abstract][Full Text] [Related]
8. Suppression of free fatty acids and triglycerides in normal and hypertriglyceridemic rats by the adenosine receptor agonist phenylisopropyladenosine.
Hoffman BB; Dall'Aglio E; Hollenbeck C; Chang H; Reaven GM
J Pharmacol Exp Ther; 1986 Dec; 239(3):715-8. PubMed ID: 3795036
[TBL] [Abstract][Full Text] [Related]
9. Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia.
Figueira TR; Vercesi AE; Oliveira HC
Lipids Health Dis; 2010 Dec; 9():146. PubMed ID: 21187011
[TBL] [Abstract][Full Text] [Related]
10. YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
Ugawa T; Kakuta H; Moritani H; Inagaki O; Shikama H
Br J Pharmacol; 2003 May; 139(1):140-6. PubMed ID: 12746232
[TBL] [Abstract][Full Text] [Related]
11. Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver.
Tessari P; Tiengo A
Acta Diabetol; 2008 Sep; 45(3):143-5. PubMed ID: 18357405
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion.
Feingold KR; Serio MK; Adi S; Moser AH; Grunfeld C
Endocrinology; 1989 May; 124(5):2336-42. PubMed ID: 2707158
[TBL] [Abstract][Full Text] [Related]
13. Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia.
Scribner KA; Gadbois TM; Gowri M; Azhar S; Reaven GM
Metabolism; 2000 Sep; 49(9):1106-10. PubMed ID: 11016888
[TBL] [Abstract][Full Text] [Related]
14. Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.
Grunfeld C; Adi S; Soued M; Moser A; Fiers W; Feingold KR
Cancer Res; 1990 Jul; 50(14):4233-8. PubMed ID: 2364381
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged.
Aarsland A; Chinkes D; Wolfe RR; Barrow RE; Nelson SO; Pierre E; Herndon DN
Ann Surg; 1996 Jun; 223(6):777-87; discussion 787-9. PubMed ID: 8645051
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats.
Ménard SL; Ci X; Frisch F; Normand-Lauzière F; Cadorette J; Ouellet R; Van Lier JE; Bénard F; Bentourkia M; Lecomte R; Carpentier AC
Mol Imaging Biol; 2009; 11(1):6-14. PubMed ID: 18769973
[TBL] [Abstract][Full Text] [Related]
17. Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats.
Yue JT; Mighiu PI; Naples M; Adeli K; Lam TK
Circ Res; 2012 May; 110(10):1345-54. PubMed ID: 22474253
[TBL] [Abstract][Full Text] [Related]
18. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice.
Memon RA; Grunfeld C; Moser AH; Feingold KR
Endocrinology; 1993 May; 132(5):2246-53. PubMed ID: 8477669
[TBL] [Abstract][Full Text] [Related]
20. Regulation of triglyceride mobilization in isolated hepatocytes by dibutyryl cyclic AMP and epinephrine.
Woodside WF; Ontko JA
J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S38-44; discussion S44. PubMed ID: 2471014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
